Veru (STU:FMW0) ROC %: -202.42% (As of Mar. 2026)

What is Veru ROC %?

Veru STU:FMW0 28 ROC % is -202.42% as of Mar. 2026. GuruFocus rates STU:FMW0 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Veru's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was -202.42%.

As of today (2026-07-03), Veru's WACC % is 3.19%. Veru's ROC % is -193.69% (calculated using TTM income statement data). Veru earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Veru (STU:FMW0) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Veru's WACC % is 3.19%. Veru's ROC % is -193.69% (calculated using TTM income statement data). Veru earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Veru ROC % Related Terms

Veru ROC % Historical Data

* Premium members only.

The historical data trend for Veru's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veru ROC % Chart

Veru Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

ROC %

Get a 7-Day Free Trial

-13.10

-207.45

-263.65

-114.49

-138.55

Veru Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROC %	Get a 7-Day Free Trial															-258.39	-216.77	-198.11	-138.96	-202.42

28GF Score

Veru Inc STU:FMW0

ROC % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Veru ROC % Calculation

Veru's annualized Return on Capital (ROC %) for the fiscal year that ended in Sep. 2025 is calculated as:

	ROC % (A: Sep. 2025 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Sep. 2024 )	+	Invested Capital (A: Sep. 2025 ))	/ count )
=	-30.272 * ( 1 - 0% )	/	( (30.756	+	12.941)	/ 2 )
=	-30.272	/	21.8485
=	-138.55 %

where

	Invested Capital		(A: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	54.438	-	2.639	-	( 23.119	-	max(0, 10.693	-	31.736	+	23.119	))
=	30.756

	Invested Capital		(A: Sep. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	25.42	-	2.996	-	( 15.609	-	max(0, 6.633	-	16.116	+	15.609	))
=	12.941

Veru's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

	ROC % (Q: Mar. 2026 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2025 )	+	Invested Capital (Q: Mar. 2026 ))	/ count )
=	-24.976 * ( 1 - 0% )	/	( (13.725	+	10.952)	/ 2 )
=	-24.976	/	12.3385
=	-202.42 %

where

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	40.622	-	1.551	-	( 30.229	-	max(0, 6.087	-	31.433	+	30.229	))
=	13.725

	Invested Capital		(Q: Mar. 2026 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	37.267	-	2.124	-	( 26.612	-	max(0, 4.661	-	28.852	+	26.612	))
=	10.952

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

Frequently Asked Questions Learn more about ROC % →

What does a ROC % of -202.42% mean?

Veru (STU:FMW0) has a ROC % of -202.42% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Veru and its competitors.

Is Veru's ROC % too high?

Veru's current ROC % is -202.42%. Overall, Veru has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.

How does Veru's ROC % compare to AURX and PDSB?

Veru's ROC % of -202.42% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROC % for a Biotechnology company?

A good ROC % depends on the Biotechnology industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROC % mean?

A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Veru and its competitors. Veru's current ROC % is -202.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Veru stock overvalued right now?

Veru (STU:FMW0) has a current ROC % of -202.42%. The current ROC % is -202.42%. Veru's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROC % calculated?

ROC % is calculated from a company's financial statements. For Veru (STU:FMW0), the current ROC % is -202.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veru Business Description

Industry Healthcare Biotechnology

Comparable Companies AURX PDSB LTRN KALA MGX HYPD TIL APLM IBO ACTU VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges VERU:USA

Address 2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127

Website https://www.verupharma.com

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

28GF Score

Get the complete analysis for STU:FMW0

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.11

Price

View STU:FMW0 Analysis

See ROC % data for all stocks →